Latest News and Press Releases

SPR announces reaching significant SPRINT PNS milestone with 50,000 treatment implants.

The American Society of Pain and Neuroscience (ASPN) published peripheral nerve stimulation (PNS) consensus guidelines supporting use of the technology.

SPR to feature eight abstracts at ASRA Fall 2025 meeting including four award-winners highlighting SPRINT PNS.

SPR to feature five abstracts at ASPN 2025 highlighting applications of the SPRINT PNS System to address pain.

ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS, offering evidence-based best practice recommendations.

For the fourth year in a row, SPR has been recognized as a Top Workplace by Northeast Ohio Top Workplaces.

SPRINT® PNS meets the primary endpoint of reduction in head pain in the first publication of multicenter prospective MONARCH™ Study.

SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List.

A new real-world retrospective analysis of patients who received 60-day PNS for chronic shoulder pain has been published in Pain Management.